Fabtech Technologies Limited (FABTECH) has successfully completed a 14,000 sqm turnkey facility for Himalaya Wellness Company in Dubai, UAE. This milestone highlights the company’s engineering prowess and project execution discipline. The facility, delivered in less than a year, supports pharmaceutical and cosmetic manufacturing operations with different cleanroom requirements.

Project Execution and Delivery

The project was managed by Fabtech’s Step Down Subsidiary, FTS Cleanrooms Systems LLC, UAE. The integrated approach to the build allowed the design, installation, and validation to be managed under a single delivery structure. This ensured the project was completed within the planned timeframe of less than a year, showcasing the efficiency of the project team.

Significance of the Facility

The completed facility forms part of Himalaya’s manufacturing operations in Dubai, providing cleanroom infrastructure for the production of pharmaceutical and cosmetic products. Mr. Aman Anavkar, Chief Growth Officer, Fabtech Technologies Limited, emphasized the importance of this project in validating the company’s engineering capabilities and project execution discipline.

As pharmaceutical manufacturing capacity expands across emerging markets, Fabtech Technologies remains focused on leveraging its engineering expertise and international presence to participate in the next phase of global healthcare infrastructure development.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Fabtech Technologies Limited

Fabtech Technologies Limited belongs to the Healthcare › Health Information Services sector. Here’s a quick read on where the business and the stock stand today.

Fabtech posts a 0.1% three-month gain, but softens in the last few weeks. The PEG of 0.64 signals undervaluation relative to growth. It is a potential re-rating candidate. Revenue grows at 28.3% and profits at 20.8% CAGR. Both numbers are exceptional. The stock gives back 0.1% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 28.3% and profits at 20.8%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Fabtech Technologies Limited.

Fabtech Technologies Limited (FABTECH) has secured an AED 9.92 million turnkey project for Aroma King, a flavour manufacturing company in the UAE, through its wholly owned subsidiary FTS Cleanrooms Systems LLC. The project, scheduled for fast-track completion within six months, will deliver the facility’s critical internal infrastructure, including modular controlled environments, cold rooms, specialised flooring, high- and low-side HVAC systems, and internal electrical works under an integrated, single-source execution model.

Expanding Critical Infrastructure Platform

Flavour manufacturing requires precise control of temperature, humidity, hygiene, and production environments to ensure consistency and product quality. This project leverages Fabtech Group’s engineering expertise in controlled environments and mission-critical infrastructure to create a modern, efficient, and future-ready manufacturing facility. The win also demonstrates the strategic role of FTS Cleanrooms Systems LLC as Fabtech’s regional execution platform, expanding the Group’s capabilities into high-specification food, flavour, and ingredient manufacturing while strengthening its presence in the UAE.

Advancing Global Vision

This project advances Fabtech’s broader vision of becoming a global critical infrastructure platform — extending its expertise in precision environments, HVAC, utilities, and integrated engineering into industries where manufacturing conditions are mission-critical. Fabtech Technologies Limited — engineering critical infrastructure for the industries of tomorrow.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Fabtech Technologies Limited

Fabtech Technologies Limited belongs to the Healthcare › Health Information Services sector. Here’s a quick read on where the business and the stock stand today.

Fabtech trades in the lower quarter of its 52-week range. The PEG of 0.65 signals undervaluation relative to growth. It is a potential re-rating candidate. Revenue grows at 28.3% and profits at 20.8% CAGR. Both numbers are exceptional. The stock sits at 12% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 28.3% and profits at 20.8% CAGR — a genuinely strong business. Nevertheless, the stock drops 3.6% in three months. The market sells the stock, not the story. Watch whether that changes at the next earnings. Check Fundamentals of Fabtech Technologies Limited.

Fabtech Technologies Limited (FABTECH) has reported strong financial results for Q1 FY2026-2027, showcasing a robust growth trajectory. The company’s revenue increased by 10.3% year-on-year, reaching ₹74.98 crore, driven by better project selection, procurement efficiency, and execution quality. Notably, the contribution margin surged to a record 46.7%, up from 37.6% in the same period last year, reflecting improved operational performance.

Revenue and Profitability

The revenue growth was consistent with the company’s growth trajectory, swinging from a ₹6.13 crore loss to a ₹4.21 crore profit in Q1 FY27. Employee costs decreased by 2.8%, indicating emerging operating leverage, while finance costs dropped by 35.9% due to the post-IPO utilization of funds. Despite the seasonal nature of the EPC business, the order inflows and pipeline remain constructive, reinforcing the company’s positive outlook for the fiscal year.

Market Performance

Fabtech Technologies Limited continues to expand its footprint globally, with a significant focus on the MEA region, which accounts for 78% of its revenue. The company’s order book and pipeline are robust, with notable increases in Saudi Arabia (+130%) and Africa (₹27.93 crore combined for Morocco and Kenya). The international revenue share stands at approximately 55%, across a presence in over 60 countries.

Strategic Direction

Looking ahead, Fabtech Technologies Limited aims for 20–25% organic growth for FY27, driven by a strong order pipeline and business visibility. The company remains committed to its strategic direction of global expansion, operational excellence, technology adoption, and capital discipline. With a focus on building infrastructure and enabling science, Fabtech aspires to become a stronger, more resilient, and globally admired institution in life sciences engineering.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Fabtech Technologies Limited

Fabtech Technologies Limited belongs to the Healthcare › Health Information Services sector. Here’s a quick read on where the business and the stock stand today.

Fabtech falls 13.8% over three months and has not found a floor yet. The PEG of 0.72 signals undervaluation relative to growth. It is a potential re-rating candidate. Revenue grows at 28.5% and profits at 20.8% CAGR. Both numbers are exceptional. The stock sits at 12% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 28.5% and profits at 20.8% CAGR, with D/E of 0.00. Meanwhile, the stock dips 13.8% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Fabtech Technologies Limited.